PathoVax Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $672K

  • Investors
  • 11

PathoVax General Information

Description

Developer of an HPV vaccine designed to combat infectious diseases. The company's product is a broad-spectrum vaccine for the treatment of human papillomavirus, enabling users to get cured of various contagious diseases.

Contact Information

Website
www.pathovax.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 1812 Ashland Avenue
  • Suite 100
  • Baltimore, MD 21205
  • United States
+1 (443)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 1812 Ashland Avenue
  • Suite 100
  • Baltimore, MD 21205
  • United States
+1 (443)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PathoVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Grant 01-Jan-2020 $672K Completed Generating Revenue
13. Accelerator/Incubator 21-May-2019 Completed Generating Revenue
12. Corporate 30-Aug-2018 Completed Startup
11. Grant 01-Jan-2018 Completed Startup
10. Grant 21-Dec-2017 Completed Startup
9. Grant 20-Dec-2017 Completed Startup
8. Grant 18-Sep-2017 Completed Startup
7. Accelerator/Incubator 28-Oct-2016 Completed Startup
6. Angel (individual) 24-May-2016 $725K $725K Completed Startup
5. Accelerator/Incubator 04-Apr-2016 Completed Startup
To view PathoVax’s complete valuation and funding history, request access »

PathoVax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PathoVax Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
United Heath Investments Corporation Minority
U. S. National Science Foundation Government
National Institutes of Allergy and Infectious Disease Government
National Cancer Institute Government
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

PathoVax FAQs

  • When was PathoVax founded?

    PathoVax was founded in 2014.

  • Where is PathoVax headquartered?

    PathoVax is headquartered in Baltimore, MD.

  • What is the size of PathoVax?

    PathoVax has 3 total employees.

  • What industry is PathoVax in?

    PathoVax’s primary industry is Biotechnology.

  • Is PathoVax a private or public company?

    PathoVax is a Private company.

  • What is PathoVax’s current revenue?

    The current revenue for PathoVax is .

  • How much funding has PathoVax raised over time?

    PathoVax has raised $3.98M.

  • Who are PathoVax’s investors?

    Johnson & Johnson Innovation - JLABS, United Heath Investments, U. S. National Science Foundation, National Institutes of Allergy and Infectious Disease, and National Cancer Institute are 5 of 11 investors who have invested in PathoVax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »